In summary, this study reported a case of ICCA harboring BRCA1 and PALB2 pathogenic variants, which exhibited rapid progression following a combination of immunotherapy, chemotherapy, and radiotherapy, but achieved partial response after receiving olaparib as salvage treatment. The gene discussed is PALB2; the disease is infantile convulsions and choreoathetosis.